K. Rajender (Raj) Reddy, M.D.
K. Rajender (Raj) Reddy, M.D.
Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine
Contact information
Division of Gastroenterology
HUP
2 Dulles
Philadelphia, PA 19104
HUP
2 Dulles
Philadelphia, PA 19104
Office: 215-662-4276
Fax: 215-349-5915
Fax: 215-349-5915
Publications
Education:
M.B.B.S.
Osmania Medical College, Hyderabad, India, 1972.
Permanent linkM.B.B.S.
Osmania Medical College, Hyderabad, India, 1972.
Selected Publications
Blonski W,Reddy KR: Evaluation of nonmalignant liver masses.Curr Gastroenterol Rep 8: 38-45, 2006.Merriman NA,Porter SB,Brensinger CM,Reddy KR,Chang KM: Racial difference in mortality among US veterans with HIV/HCV coinfection. Am J Gastroenterol 101: 760-767, 2006.
Porrett PM,Peterman H, Rosen M,Sonnad S, Soulen M,Markmann JF,Shaked A,Furth E,Reddy KR,Olthoff K: Lack of benefit of pre-transplant locoregional hepatic artery therapy for hepatocellular carcinoma in the current MELD era. Liver Transpl 12(4): 665-673, 2006.
Itkin M,Trerotola SO, Stavropoulos SW,Patel A,Mondschein JI,Soulen MC,Tuite CM,Shlansky-Goldberg RD,Faust TW,Reddy KR,Solomon JA,Clark TW: Portal flow and arterioportal shunting after transjugular intrahepatic portosystemic shunt creation J Vasc Interv Radiol 17: 55-62, 2006.
Howell CD,Jeffers LS,Cassidy W, Reddy KR,Hu S,Lee JS: Peginterferon alfa-2a and ribavirin for chronic hepatitis C genotype 1 infections in black patients:Safety,tolerability and impact on sustained virologic response. Journal of Viral Hepatitis 13: 371-376, 2006.
Dickson RC,Terrault NA,Ishitani M,Reddy KR,Sheiner P,Luketic V,Soldevila-Pico C, Fried M, Jensen D,Brown RS Jr,Horwith G,Brundage R,Lok A: Protective antibody levels and dose requirements for IV 5 % Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease. Liver Transpl 12: 124-133, 2006.
Kotlyar DS,Campbell MS,Reddy KR: Recurrence of diseases following orthotopic liver transplantation. Am J Gastroenterol 101: 1370-1378, 2006.
Kozin ED,Reddy KR: Is long-term survivial of liver transplant recipients improved by mycophenalate mofetil combination therapy ? Nat Clin Pract Gastroenterol Hepatol 3: 132-133, 2006.
Jensen DM,Morgan TR,Marcellin P,Pockros PJ,Reddy KR,Hadziyannis SJ,Ferenci P,Ackrill AM, Willems B: Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a(40 kd)/ribavirin therapy. Hepatology 43: 954-960, 2006.
Ferenci P,Fried MW,Shiffman ML,Smith CI,Marinos G,Goncales FL,Haussinger D,Diago M,Carosi G,Dhumeaux D,Craxi A,Chaneac M,Reddy KR: Predicting sustained virologic responses in chronic hepatitis C patients treated with peginterferon alfa-2a(40 KD)/ribavirin. J Hepatol 43: 425-433, 2005.